Kimrox 250 Tablet contains Cefuroxime 250mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is indicated for the treatment of respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. Kimrox 250 is also used in the management of otitis media and sinusitis caused by susceptible organisms. The tablet formulation ensures convenient oral administration with good bioavailability. Dosage and duration of therapy should be determined based on the severity and type of infection, as well as patient-specific factors including renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, as well as hypersensitivity reactions in patients with a history of penicillin or cephalosporin allergy. Use with caution in patients with renal impairment and monitor for signs of superinfection with prolonged use. Kimrox 250 should be stored in a cool, dry place, away from direct sunlight. It is essential to complete the full prescribed course to prevent the development of antibiotic resistance.